Epigenetics Market Poised for Robust 18% CAGR Growth Driven by R&D and Therapeutics Demand
The epigenetics market is expected to grow significantly in the coming years, reaching $4.3 billion by 2028 at a CAGR of 18.3% from 2023-2028. The growth is driven by increased investment in epigenetics research and the rising demand for epigenetic-based therapeutics. However, limited applications in toxicology and quality concerns over antibodies may restrain market growth. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=896 The kits and reagents segment, which includes antibodies, ChiP-seq kits, bisulfite conversion kits, and more, is expected to hold the dominant position in the epigenetics market during the forecast period. This is due to the development of advanced, easy-to-use, and affordable epigenetics kits and reagents. North America accounted for the largest share of the epigenetics market in 2022 due to the presence of epigenetic manufacturing companies in the region and favorable government and private initiatives supporting th...